Amit D. Munshi

Amit D. Munshi has been a member of our Board of Directors since 2020. Mr. Munshi has more than 30 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management.  He currently serves as Chairman and Chief Executive Officer of ReNAgade Therapeutics and previously served as the President and CEO of Arena Pharmaceuticals until its acquisition by Pfizer in March 2022. Previously, Mr. Munshi served as President and Chief Executive Officer of Epirus Biopharmaceuticals and Percivia LLC, and prior to that, was a co-founder and served as Chief Business Officer of Kythera Biopharmaceuticals. Earlier in his career, he held multiple leadership positions at Amgen, including General Manager, Nephrology Europe. Mr. Munshi currently serves on the board of directors of Enterprise Therapeutics Ltd, Pulmatrix, ReNAgade and Zura Bio Inc., and previously served on the board of multiple public and private boards, including Arena Pharmaceuticals. Mr. Munshi holds a B.S. in Economics and a B.A. in History from the University of California, Riverside, and an M.B.A. from the Peter F. Drucker School of Management at Claremont Graduate University, where he currently serves as an advisor and lecturer.